X0202 4 2004-06-09 0 0001274913 INHIBITEX INC INHX 0001279817 BLAIR WILLIAM CAPITAL PARTNERS VI LP 227 W. MONROE STREET SUITE 3500 CHICAGO IL 60606 0 0 1 0 Common Stock 2004-06-09 4 C 0 2213119.0000 A 2341690.0000 D Series C Convertible Preferred Stock 2004-06-09 4 J 0 791925.0000 A Common Stock 332742.0000 3423504.0000 D Series D Convertible Preferred Stock 2004-06-09 4 J 0 168589.0000 A Common Stock 70836.0000 1082296.0000 D Series C Convertible Preferred Stock 2004-06-09 4 C 0 3423504.0000 D Common Stock 1438447.0000 0 D Series D Convertible Preferred Stock 2004-06-09 4 C 0 1082296.0000 D Common Stock 454747.0000 0 D Series E Convertible Preferred Stock 2004-06-09 4 C 0 761421.0000 D Common Stock 319925.0000 0 D The securities automatically converted on a 1-for-2.38 basis into Common Stock upon the closing of the initial public offering of the Issuer. The securities convert on a 1-for-2.38 basis into Common Stock, giving effect to the recently completed 1-for-2.38 reverse stock split of the Common Stock. The securities were acquired upon the election of the Reporting Person to receive accumulated dividends on the Issuer's Series C Convertible Preferred Stock (the "Series C Stock") in Series C Stock. Such Series C Stock converted to Common Stock upon the closing of the inital public offering of Common Stock of the Issuer as described in Footnote 1. The securities are immediately convertible. The securities have no expiration date. The securities were acquired upon the election of the Reporting Person to receive accumulated dividends on the Issuer's Series D Convertible Preferred Stock (the "Series D Stock") in Series D Stock. Such Series D Stock converted to Common Stock upon the closing of the initial public offering of Common Stock of the Issuer as described in footnote 1. /s/ Melissa P. Coyne attorney-in-fact for William Blair Capital Partners VI, L.P. 2004-06-09